Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events

References

• GrundySMCleemanJIMerzCNImplications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesCirculation200411022723915249516
   PubMed Web of Science ®Google Scholar
• De BackerGAmbrosioniEBorch-JohnsenKBrotonsCCifkovaRDallongevilleJEuropean guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical PracticeEur Heart J2003241601161012964575
   PubMed Web of Science ®Google Scholar
• GrahamIAtarDBorch-JohnsenKEuropean guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)Eur Heart J2007282375241417726041
   PubMed Web of Science ®Google Scholar
• DelahoyPJMaglianoDJWebbKGroblerMLiewDThe relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta-analysisClin Ther20093123624419302897
   PubMed Web of Science ®Google Scholar
• BaigentCBlackwellLEmbersonJEfficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trialsLancet20103761670168121067804
   PubMed Web of Science ®Google Scholar
• ConroyRMPyöräläKFitzgeraldAPEstimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectEur Heart J200324987100312788299
   PubMed Web of Science ®Google Scholar
• Läkemedelsverket (Medical Products Agency)Förebyggande av aterosklerotisk hjärt-kärlsjukdom. Version2006173 Available from: http://www.lakemedelsverket.se/upload/halso-och-sjukvard/behandlingsrekommendationer/080313_primarprevention.pdfAccessed May 9, 2011
   Google Scholar
• RidkerPMRifaiNRoseLBuringJECookNRComparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular eventsN Engl J Med20023471557156512432042
   PubMed Web of Science ®Google Scholar
• RidkerPMDanielsonEFonsecaFARosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinN Engl J Med20083592195220718997196
   PubMed Web of Science ®Google Scholar
• OhsfeldtRLGandhiSKSmolenLJCost effectiveness of rosuvastatin in patients at risk of cardiovascular disease based on findings from the JUPITER trialJ Med Econ20101342843720662625
   PubMedGoogle Scholar
• National Institutes of Health92002Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final ReportNational Institutes of Health Publication No. 02-5215
   Google Scholar
• Tandvårds-och Läkemedelsformånsverket (Swedish Dental and Pharmaceutical Benefits Agency)General Guidelines for Economic Evaluations from the Pharmaceutical Benefits Board (LFNAR 2003:2) Available from: http://www.tlv.seAccessed November 9, 2011
   Google Scholar
• HolmanRRColemanRLShineBSStevensRJNon-HDL cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetesDiabetes Care2005281796179715983339
   PubMed Web of Science ®Google Scholar
• TohidiMHatamiMHadaeghFSafarkhaniMHaratiHAziziFLipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort studyLipids Health Dis20109620096127
   PubMed Web of Science ®Google Scholar
• FordIMurrayHPackardCJShepherdJMacFarlanePWCobbeSMLong-term follow-up of the West of Scotland Coronary Prevention StudyN Engl J Med20073571477148617928595
   PubMed Web of Science ®Google Scholar
• AvornJMonetteJLacourAPersistence of use of lipid-lowering medications: a cross-national studyJAMA1998279145814629600480
   PubMed Web of Science ®Google Scholar
• WardSLloydJMPandorAA systematic review and economic evaluation of statins for the prevention of coronary eventsHealth Technol Assess2007111160iiiiv
   Web of Science ®Google Scholar
• GlynnRJDanielsonEFonsecaFAA randomized trial of rosuvastatin in the prevention of venous thromboembolismN Engl J Med20093601851186119329822
   PubMed Web of Science ®Google Scholar
• Statistika Centralbrån (Statistics Sweden) Available from: http://www.scb.se/Accessed May 9, 2011
   Google Scholar
• The Framingham Heart StudyFramingham Heart Study, Coronary Heart Disease (10-year risk) Available from: http://www.framinghamheartstudy.org/risk/coronary.htmlAccessed May 9, 2011
   Google Scholar
• AndersonKMOdellPMWilsonPWKannelWBCardiovascular disease risk profilesAm Heart J19911211 Pt 22932981985385
   PubMed Web of Science ®Google Scholar
• JonesPHHunninghakeDBFerdinandKCEffects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trialClin Ther2004261388139915531001
   PubMed Web of Science ®Google Scholar
• SchneckDWKnoppRHBallantyneCMMcPhersonRChitraRRSimonsonSGComparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial diseaseAm J Cardiol200391334112505568
   PubMed Web of Science ®Google Scholar
• Swedish Association of Local Authorities and Regions Available from: http://www.skl.se/web/Hem.aspxAccessed May 9, 2011
   Google Scholar
• SigvantBEpidemiological aspects of peripheral arterial diseaseDepartment of Molecular Medicine and SurgeryStockholm, SwedenKarolinska Institute2009 Available from: http://diss.kib.ki.se/2009/978-91-7409-670-5/thesis.pdfAccessed May 9, 2011
   Google Scholar
• GhatnekarOPerssonUGladerELTerentACost of stroke in Sweden: an incidence estimateInt J Technol Assess Health Care20042037538015446769
   PubMed Web of Science ®Google Scholar
• SullivanPWArantTWEllisSLUlrichHThe cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the USPharmacoeconomics2006241021103317002484
   PubMed Web of Science ®Google Scholar
• GoodacreSNichollJDixonSRandomized controlled trial and economic evaluation of a chest pain observation unit compared with routine careBMJ200432825414724129
   PubMed Web of Science ®Google Scholar
• ScuffhamPAKosaJThe cost-effectiveness of fluvastatin in Hungary following successful percutaneous coronary interventionCardiovasc Drugs Ther20062030931716779529
   PubMed Web of Science ®Google Scholar
• TengsTOLinTHA meta-analysis of quality-of-life estimates for strokePharmacoeconomics20032119120012558469
   PubMed Web of Science ®Google Scholar
• ShihYCHanSCantorSBImpact of generic drug entry on cost-effectiveness analysisMed Decis Making200525718015673583
   PubMed Web of Science ®Google Scholar
• HoyleMFuture drug prices and cost-effectiveness analysesPharmacoeconomics20082658960218563950
   PubMed Web of Science ®Google Scholar
• Pharmaceutical Management AgencyPrescription for pharmacoeconomic analysis: methods for cost-utility analysis52007 Available from: http://www.pharmac.govt.nz/2007/06/19/PFPAFinal.pdfAccessed May 9, 2011
   Google Scholar
• EichlerHGKongSXGerthWCMavrosPJonssonBUse of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?Value Health2004751852815367247
   PubMed Web of Science ®Google Scholar
• CutlerDMRosenABVijanSThe value of medical spending in the United States, 1960–2000N Engl J Med200635592092716943404
   PubMed Web of Science ®Google Scholar
• BlomstromPEkmanMLundqvistCBCost effectiveness of cardiac resynchronization therapy in the Nordic region: an analysis based on the CARE-HF trialEur J Heart Fail20081086987718684664
   PubMed Web of Science ®Google Scholar
• PerssonUHjelmgrenJHealth services need knowledge of how the public values healthLakartidningen200310034363437 Swedish14626774
   PubMedGoogle Scholar
• CarlhedRBojestigMPetersonAImproved clinical outcome after acute myocardial infarction in hospitals participating in a Swedish quality improvement initiativeCirc Cardiovasc Qual Outcomes2009245846420031877
   PubMed Web of Science ®Google Scholar
• National Health Statistics Reports. No. 5, July 30, 20082006 National Hospital Discharge Survey Available from: http://www.cdc.gov/nchs/data/nhsr/nhsr005.pdfAccessed May 9, 2011
   Google Scholar
• National Adult Cardiac Surgical Database Report 1999–2000The United Kingdom Cardiac Surgical Register Available from: http://www.scts.org/file/NACSDreport2000ukcsr.pdfAccessed May 9, 2011
   Google Scholar
• British Cardiovascular Intervention SocietyUnited Kingdom national PCI audit data Available from: http://www.bcis.org.uk/pages/page_box_contents.asp?pageid=697&navcatid=11Accessed May 9, 2011
   Google Scholar